drugset / Trial / NCT00872885
Bunionectomy Trial With GRT6005
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of the trial is to determine whether the new centrally acting analgesic is effective in comparison to placebo and an active comparator (morphine).
Timeline
- Start
- 2009-03
- Primary completion
- 2009-08
- Completion
- 2009-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cebranopadol | Small molecule | 200 ug | — |
| Subject | Cebranopadol | Small molecule | 600 ug | — |
| Comparator | Morphine | Other / unclassified | 60 mg | — |
Indications
No indication recorded.